Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine
Recent studies challenge the traditional view of venous thromboembolism as a direct cause of unexplained fevers, emphasizing the need for comprehensive diagnostic evaluations.
Emergency Medicine January 11th 2024
Rare Disease Advisor
Uncover the groundbreaking advancements in PNH treatment, from oral therapies to dual inhibition strategies, and their implications for patient outcomes.
Hematology January 2nd 2024
Hematology Advisor
Explore the profound impact of Social Determinants of Health on mantle cell lymphoma outcomes and the potential of novel therapies in reducing these disparities.
Explore the complex interplay between MTHFR gene variants and thrombosis risk. This deep dive into the latest research reveals surprising insights.
Cardiology November 15th 2023
The study’s findings suggest that palliative radiotherapy could be a viable option for managing pain in multiple myeloma patients. With a complete response rate of 48% and a partial response rate of 38%, this treatment approach shows promise.
Hematology November 6th 2023
DocWire News
The study’s findings suggest a potential paradigm shift in the management of cancer patients with isolated distal DVT. With the 12-month edoxaban regimen reducing the occurrence of the primary composite endpoint to just 1.0% compared to 7.2% in the three-month group, this could represent a significant advancement in patient care.